ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,823Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 623

$727K Total Retail Price of All Prescriptions

Rank: 14 out of 623

324 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 324 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 324 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 9,224 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
FUROSEMIDE 377 354 1 5
LISINOPRIL 351 316 2 1
LEVOTHYROXINE SODIUM 320 293 3 4
CITALOPRAM HBR 312 295 4 21
OMEPRAZOLE 305 284 5 7
PRAVASTATIN SODIUM 243 216 6 11
PANTOPRAZOLE SODIUM 205 170 7 26
AMLODIPINE BESYLATE 194 170 8 3
HYDROCHLOROTHIAZIDE 185 156 9 8
DONEPEZIL HCL 171 162 10 27
SIMVASTATIN 170 124 11 2
TRAMADOL HCL 167 140 12 15
HYDROCODONE-ACETAMINOPHEN 165 128 S3 13 17
METOPROLOL TARTRATE 155 135 14 9
POTASSIUM CHLORIDE 153 126 15 24
WARFARIN SODIUM 141 132 16 14
CYMBALTA 139 109 17 52
ATORVASTATIN CALCIUM 134 120 18 10
PREDNISONE 131 109 19 40
GABAPENTIN 129 123 20 18
LOSARTAN POTASSIUM 125 120 21 16
NAMENDA 124 124 22 47
ISOSORBIDE MONONITRATE ER 122 122 23 64
POLYETHYLENE GLYCOL 3350 119 108 24 53
ATENOLOL 109 84 25 12
RANITIDINE HCL 108 81 26 23
TRAZODONE HCL 107 90 27 36
CARVEDILOL 95 93 28 32
METFORMIN HCL 90 75 29 6
METOPROLOL SUCCINATE 90 75 29 13
LANTUS 86 64 31 41
CIPROFLOXACIN HCL 85 76 32 61
EXELON 84 82 33 125
FENTANYL 79 73 S2 34 76
OXYCODONE-ACETAMINOPHEN 72 66 S2 35 42
DIOVAN 72 72 35 48
ALBUTEROL SULFATE 68 68 37 69
OLANZAPINE 67 54 38 120
MIRTAZAPINE 67 66 38 31
ZOLPIDEM TARTRATE 67 50 38 22
OXYCONTIN 66 26 S2 41 137
ABILIFY 66 20 41 166
OXYCODONE HCL 62 29 S2 43 30
RISPERIDONE 62 62 43 49
FLUTICASONE PROPIONATE 62 35 43 29
ADVAIR DISKUS 61 37 46 39
ALLOPURINOL 60 60 47 44
LYRICA 60 48 47 86
TAMSULOSIN HCL 58 58 49 35
KLOR-CON M20 58 47 49 62
LEVOFLOXACIN 57 50 51 72
ESCITALOPRAM OXALATE 56 47 52 60
CARTIA XT 55 45 53 267
NOVOLOG 54 34 54 75
SPIRIVA 53 45 55 58
LOVASTATIN 53 45 55 25
GLIPIZIDE 53 39 55 33
INSULIN SYRINGE 53 39 55 80
OXYBUTYNIN CHLORIDE ER 51 50 59 193
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 3, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.